TherapeuticsMD (TXMD) EBT Margin (2009 - 2026)
TherapeuticsMD (TXMD) reported EBT Margin of 18.87% for Q2 2026, down 38.38 percentage points from 57.25% a year earlier but up 4.65 percentage points from the prior quarter.
TherapeuticsMD (TXMD) EBT Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, TherapeuticsMD's EBT Margin came in at -8.04%, up 15.68 percentage points year-over-year; for FY2025, it came in at -21.61%, up 111.44 percentage points from FY2024.
- EBT Margin has a five-year change of +261.29 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -133.05% in FY2024 (+461.57 pp), -594.62% in FY2023 (-596.16 pp), 1.54% in FY2022 (+3083.73 pp) and -3082.20% in FY2021 (-2799.30 pp).
- Five-year quarterly EBT Margin spans a low of -4273.85% in Q2 2022 and a high of 268.50% in Q4 2021.
- Year over year, EBT Margin gained in six of the last eight quarters, with an average year-over-year change of +462.86 percentage points.
- The high point for year-over-year EBT Margin in five years was Q2 2023 (a gain of 3721.45 percentage points); the low point was Q2 2022 (a drop of 4088.42 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 14.23% (Q1 2026), -64.95% (Q4 2025) and 6.38% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | TherapeuticsMD | 20.14 Mn | -12.07 Mn | - | 18.87% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.87% |
| Mar 31, 2026 | 14.23% |
| Dec 31, 2025 | -64.95% |
| Sep 30, 2025 | 6.38% |
| Jun 30, 2025 | 57.25% |
| Mar 31, 2025 | -169.97% |
| Dec 31, 2024 | 12.44% |
| Sep 30, 2024 | -103.66% |
| Jun 30, 2024 | -448.72% |
| Mar 31, 2024 | -258.47% |
| Dec 31, 2023 | -315.54% |
| Sep 30, 2023 | -2,705.66% |
| Jun 30, 2023 | -552.40% |
| Mar 31, 2023 | -555.29% |
| Dec 31, 2022 | 70.67% |
| Sep 30, 2022 | -4,133.05% |
| Jun 30, 2022 | -4,273.85% |
| Mar 31, 2022 | -2,571.94% |
| Dec 31, 2021 | 268.50% |
| Sep 30, 2021 | -186.65% |
TherapeuticsMD EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();